International organization OIC, Medi Mold, and Fives-AddUp Establish Strategic Partnership
The strategic partnership between OIC International (USA), Medi Mold (India), and AddUp (France) is progressing to establish an advanced orthopedic implant manufacturing facility in India. This facility, to be housed within AMTZ, India's flagship medical device manufacturing park in Visakhapatnam, will leverage AddUp’s industrial FormUp metal 3D printing technology for mass production of patient-specific orthopedic implants.
The collaboration supports India’s “Make in India” and medical self-reliance initiatives by combining OIC International’s market presence, Medi Mold’s local manufacturing platform, and AddUp’s expertise in metal additive manufacturing. The focus is on delivering cost-effective, customized, and high-performance implants both for domestic use and international markets, improving supply chain traceability, production efficiency, and regulatory compliance.
The new facility will enable rapid prototyping and full-scale production of implants, high traceability for regulatory purposes, reduced manufacturing costs and material waste, faster time to market for patient-specific implants, and support for both public healthcare schemes and private hospitals.
The initiative is well-supported by key stakeholders, including AMTZ CEO Dr. Jitendra Sharma, who sees AMTZ as the right place for 3D printed implant production in India. As of early August 2025, the initiative is moving from planning into operational execution, with the first AddUp FormUp metal 3D printer installation underway, marking tangible progress toward the facility’s launch.
The partnership aims to address technology-led innovation, affordability, and market access in orthopedics. It is expected to transform India into a global hub for high-performance orthopedic implants, offering an integrated manufacturing platform for low-cost implants for public sector procurement, supporting government hospitals and healthcare schemes.
Wodehouse Capital Advisors, Mumbai, has noted significant investor interest in this opportunity, from both financial and strategic players looking to tap into India's rapidly growing medical devices sector. The project aligns with the Indian government's "Make in India" and medical self-reliance initiatives, and the strategic arrangement is expected to be concluded in the next few weeks, subject to necessary approvals.
This venture is a testament to the vision of AMTZ, which has played a catalytic role in anchoring the partnership and enabling the infrastructure required to fast-track India's med-tech innovation. The new facility, powered by 3D printing and precision engineering, aims to significantly reduce post-surgery recovery time and deliver cutting-edge solutions at a fraction of the cost.
- This partnership between OIC International, Medi Mold, and AddUp, with AMTZ as the host, is utilizing AddUp’s metal 3D printing technology to produce affordable, high-performance orthopedic implants for both domestic and international markets.
- The initiative supports India’s "Make in India" and medical self-reliance goals, aiming to transform the country into a global hub for orthopedic implants using a low-cost manufacturing platform.
- Wodehouse Capital Advisors, Mumbai, has reported growing investor interest in this venture, giving potential for financial and strategic gains, as it aligns with India's expanding medical devices sector and government initiatives.
- The strategic arrangement, expected to close soon, is backed by AMTZ, which has played a crucial role in facilitating the partnership and the infrastructure necessary to accelerate India's med-tech innovation, ultimately delivering advanced solutions to decrease post-surgery recovery time at a fraction of the cost.
